Safety of Patients Isolated for Infection Control
Overview
Affiliations
Context: Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors.
Objective: To examine the quality of medical care received by patients isolated for infection control.
Design, Setting, And Patients: We identified consecutive adults who were isolated for methicillin-resistant Staphylococcus aureus colonization or infection at 2 large North American teaching hospitals: a general cohort (patients admitted with all diagnoses between January 1, 1999, and January 1, 2000; n = 78); and a disease-specific cohort (patients admitted with a diagnosis of congestive heart failure between January 1, 1999, and July 1, 2002; n = 72). Two matched controls were selected for each isolated patient (n = 156 general cohort controls and n = 144 disease-specific cohort controls).
Main Outcome Measures: Quality-of-care measures encompassing processes, outcomes, and satisfaction. Adjustments for study cohort and patient demographic, hospital, and clinical characteristics were conducted using multivariable regression.
Results: Isolated and control patients generally had similar baseline characteristics; however, isolated patients were twice as likely as control patients to experience adverse events during their hospitalization (31 vs 15 adverse events per 1000 days; P<.001). This difference in adverse events reflected preventable events (20 vs 3 adverse events per 1000 days; P<.001) as opposed to nonpreventable events (11 vs 12 adverse events per 1000 days; P =.98). Isolated patients were also more likely to formally complain to the hospital about their care than control patients (8% vs 1%; P<.001), to have their vital signs not recorded as ordered (51% vs 31%; P<.001), and more likely to have days with no physician progress note (26% vs 13%; P<.001). No differences in hospital mortality were observed for the 2 groups (17% vs 10%; P =.16).
Conclusion: Compared with controls, patients isolated for infection control precautions experience more preventable adverse events, express greater dissatisfaction with their treatment, and have less documented care.
Greening Infection Prevention and Control: Multifaceted Approaches to a Sustainable Future.
Lee P, Frantzis I, Abeles S Open Forum Infect Dis. 2025; 12(2):ofae371.
PMID: 39958523 PMC: 11825990. DOI: 10.1093/ofid/ofae371.
Sigakis M, Posluszny J, Maile M, Jewell E, Engoren M Infect Prev Pract. 2024; 6(4):100413.
PMID: 39624778 PMC: 11609449. DOI: 10.1016/j.infpip.2024.100413.
Contact precautions for MRSA and VRE: where are we now? A survey of the Research Network.
Martin E, Morgan D, Pryor R, Bearman G Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e137.
PMID: 39346664 PMC: 11428003. DOI: 10.1017/ash.2024.350.
AlRawashdeh M, Ishak A, Al-Bunnia A, Agouridis A, Lytras T, Spernovasilis N Pathogens. 2024; 13(9).
PMID: 39339008 PMC: 11435282. DOI: 10.3390/pathogens13090817.
Doff Thy Gown-Shedding Contact Precautions for COVID-19.
Rabin A, Marr L, Blumberg H Clin Infect Dis. 2024; 79(3):585-587.
PMID: 38747695 PMC: 11426274. DOI: 10.1093/cid/ciae276.